Tonix Pharmaceuticals Holding Corp.
TNXP
$17.82
$0.633.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -130.04M | -135.25M | -149.01M | -98.59M | -116.66M |
| Total Depreciation and Amortization | 3.42M | 3.95M | 4.42M | 4.37M | 4.29M |
| Total Amortization of Deferred Charges | 840.00K | 878.00K | 907.00K | 540.00K | 0.00 |
| Total Other Non-Cash Items | 59.08M | 62.07M | 62.63M | 2.29M | 10.40M |
| Change in Net Operating Assets | 5.78M | -278.00K | 7.84M | 4.72M | -35.00K |
| Cash from Operations | -60.93M | -68.64M | -73.22M | -86.67M | -102.00M |
| Capital Expenditure | -120.00K | -555.00K | -2.36M | -4.20M | -7.90M |
| Sale of Property, Plant, and Equipment | -- | 7.00K | 999.00K | 999.00K | 999.00K |
| Cash Acquisitions | -- | 0.00 | 0.00 | -22.17M | -22.17M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -120.00K | -548.00K | -1.36M | -25.38M | -29.07M |
| Total Debt Issued | -- | 8.94M | 8.94M | 8.94M | 8.94M |
| Total Debt Repaid | -2.35M | -1.65M | -940.00K | -235.00K | -- |
| Issuance of Common Stock | 147.46M | 69.44M | 30.59M | 19.23M | 21.77M |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | 0.00 | -13.97M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10.24M | 13.69M | 15.21M | 19.87M | 19.77M |
| Cash from Financing | 134.87M | 90.43M | 53.80M | 47.81M | 36.52M |
| Foreign Exchange rate Adjustments | 4.00K | -30.00K | -25.00K | -26.00K | -65.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 73.83M | 21.22M | -20.80M | -64.27M | -94.62M |